Russell Investments Group’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.9K Sell
121,039
-24,233
-17% -$6.76K ﹤0.01% 3809
2026
Q1
$47.7K Sell
145,272
-25,799
-15% -$40.5K ﹤0.01% 3343
2025
Q4
$530K Sell
171,071
-513,978
-75% -$1.47M ﹤0.01% 2476
2025
Q3
$1.8M Buy
+685,049
New +$1.51M ﹤0.01% 1909
2024
Q2
Sell
-16,907
Closed -$19.9K 3597
2024
Q1
$19.9K Buy
16,907
+4,707
+39% +$5.18K ﹤0.01% 2771
2023
Q4
$11.1K Buy
12,200
+5,399
+79% +$3.99K ﹤0.01% 2815
2023
Q3
$5.3K Sell
6,801
-4,843
-42% -$5.58K ﹤0.01% 3134
2023
Q2
$14K Buy
11,644
+6,801
+140% +$8.47K ﹤0.01% 2907
2023
Q1
$6.1K Buy
4,843
+2,494
+106% +$4.77K ﹤0.01% 2934
2022
Q4
$5.1K Sell
2,349
-36,674
-94% -$302K ﹤0.01% 2865
2022
Q3
$466K Buy
39,023
+35,225
+927% +$437K ﹤0.01% 2274
2022
Q2
$31K Sell
3,798
-36,804
-91% -$285K ﹤0.01% 2762
2022
Q1
$351K Sell
40,602
-12,933
-24% -$125K ﹤0.01% 2328
2021
Q4
$604K Sell
53,535
-18,771
-26% -$223K ﹤0.01% 2374
2021
Q3
$908K Sell
72,306
-8,793
-11% -$80.9K ﹤0.01% 2231
2021
Q2
$658K Sell
81,099
-6,525
-7% -$56.6K ﹤0.01% 2488
2021
Q1
$809K Sell
87,624
-8,400
-9% -$84.7K ﹤0.01% 2332
2020
Q4
$928K Sell
96,024
-21,725
-18% -$214K ﹤0.01% 2149
2020
Q3
$1.46M Buy
117,749
+48,349
+70% +$641K ﹤0.01% 1875
2020
Q2
$900K Buy
69,400
+64,580
+1,340% +$812K ﹤0.01% 2119
2020
Q1
$48K Sell
4,820
-26,481
-85% -$346K ﹤0.01% 2871
2019
Q4
$487K Buy
+31,301
New +$630K ﹤0.01% 2404

Other funds holding GOSS

Russell Investments Group's GOSS Position: Q2 2026 in Review

Russell Investments Group reduced its Gossamer Bio (GOSS) stake by 17% in Q2 2026, selling an estimated $6.76K and leaving 121,039 shares worth $19.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3809.

Russell Investments Group first reported a position in GOSS in Q4 2019 and has held it in 22 quarters since. The position peaked at $1.8M in Q3 2025. 73 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Russell Investments Group held 121,039 shares of Gossamer Bio worth $19.9K as of Q2 2026.
  • Russell Investments Group sold 24,233 Gossamer Bio shares in Q2 2026, an estimated $6.76K.
  • Gossamer Bio made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3809 holding.
  • Russell Investments Group first reported a position in Gossamer Bio in Q4 2019 and has held it in 22 quarters since.
  • Russell Investments Group's Gossamer Bio position peaked at $1.8M in Q3 2025.
  • 73 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.